A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	American Society for Clinical investigation 2021-08-01
Reeks:	JCI Insight
Onderwerpen:	Immunology Metabolism
Online toegang:	https://doi.org/10.1172/jci.insight.149217

Gelijkaardige items

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
door: Ingrid G Rekeland, et al.
Gepubliceerd in: (2022-01-01)

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
door: Ingrid G. Rekeland, et al.
Gepubliceerd in: (2022-01-01)

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
door: Ingrid G Rekeland, et al.
Gepubliceerd in: (2024-01-01)

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
door: Kari Sørland, et al.
Gepubliceerd in: (2021-03-01)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
door: Øystein Fluge, et al.
Gepubliceerd in: (2015-01-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
door: Sigrid Lunde, et al.
Gepubliceerd in: (2016-01-01)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
door: Marthe Ueland, et al.
Gepubliceerd in: (2022-07-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
door: Mella Olav, et al.
Gepubliceerd in: (2009-07-01)

Medical School Education on Myalgic Encephalomyelitis
door: Nina Muirhead, et al.
Gepubliceerd in: (2021-05-01)

Myalgic encephalomyelitis - enigma at the medicine’s crossroads
door: Pavlović Dragan M., et al.
Gepubliceerd in: (2021-01-01)

Myalgic Encephalomyelitis (ME) or What? An Operational Definition
door: Frank Twisk
Gepubliceerd in: (2018-09-01)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
door: Frank Twisk
Gepubliceerd in: (2018-12-01)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome.
door: Maureen R Hanson
Gepubliceerd in: (2023-08-01)

‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
door: Rosamund Vallings
Gepubliceerd in: (2022-01-01)

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME)
door: Nadia S. Ahmed, et al.
Gepubliceerd in: (2018-01-01)

Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME)
door: Rachel L. Wilson, et al.
Gepubliceerd in: (2018-08-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
door: Øystein Fluge, et al.
Gepubliceerd in: (2011-01-01)

Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis.
door: Butler, C, et al.
Gepubliceerd in: (1996)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
door: Nadja Scherbakov, et al.
Gepubliceerd in: (2020-06-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
door: Maria Eugenia Ariza
Gepubliceerd in: (2021-01-01)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
door: Alexandra H. Mandarano, et al.
Gepubliceerd in: (2018-01-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
door: Iñigo Murga Gandasegui, et al.
Gepubliceerd in: (2021-09-01)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
door: Sabine Gravelsina, et al.
Gepubliceerd in: (2022-10-01)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
door: Daniel Missailidis, et al.
Gepubliceerd in: (2019-07-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
door: Mateo Cortes Rivera, et al.
Gepubliceerd in: (2019-08-01)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
door: Lily Chu, et al.
Gepubliceerd in: (2019-02-01)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
door: Anthony L. Komaroff, et al.
Gepubliceerd in: (2021-01-01)

An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
door: Keng Ngee Hng, et al.
Gepubliceerd in: (2021-08-01)

Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis
door: Kenny L. De Meirleir, et al.
Gepubliceerd in: (2018-11-01)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
door: Sharpe, M, et al.
Gepubliceerd in: (2021)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
door: White, PD, et al.
Gepubliceerd in: (2022)

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
door: Mawulorm K. I. Denu, et al.
Gepubliceerd in: (2025-01-01)

Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?
door: A. F. M. Towheedur Rahman, et al.
Gepubliceerd in: (2025-01-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
door: D. Peterson, et al.
Gepubliceerd in: (2015-01-01)

Development of an expert system for the classification of myalgic encephalomyelitis/chronic fatigue syndrome
door: Fatma Hilal Yagin, et al.
Gepubliceerd in: (2024-03-01)

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
door: Brian Walitt, et al.
Gepubliceerd in: (2024-02-01)

Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls
door: Joshua J Dibble, et al.
Gepubliceerd in: (2024-01-01)

Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
door: Koki Li, et al.
Gepubliceerd in: (2021-03-01)

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
door: Alaa Ghali, et al.
Gepubliceerd in: (2022-10-01)

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
door: Santiago Herrera, et al.
Gepubliceerd in: (2018-12-01)